People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of the price and not approved by the FDA ...
The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold to US consumers.
Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...
The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.
A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...
More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...
More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously ...
Jim Cramer recently talked about the market selloff and how years of profits are lost within days when panic hits the market: ...
20h
MarketBeat on MSNIs Viking Therapeutics the Next Blockbuster GLP-1 Stock?When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...
For decades, the United States has led the world in pharmaceutical innovation -- developing drugs that combat cancer, heart disease, AIDS, diabetes and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results